| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13197* | 2021 |
| How do cytotoxic lymphocytes kill cancer cells? L Martínez-Lostao, A Anel, J Pardo Clinical cancer research 21 (22), 5047-5056, 2015 | 741 | 2015 |
| Interactions of long-chain fatty acids and albumin: determination of free fatty acid levels using the fluorescent probe ADIFAB GV Richieri, A Anel, AM Kleinfeld Biochemistry 32 (29), 7574-7580, 1993 | 443 | 1993 |
| Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles MJ Martínez-Lorenzo, A Anel, S Gamen, I Monleón, P Lasierra, L Larrad, ... The Journal of Immunology 163 (3), 1274-1281, 1999 | 375 | 1999 |
| Onto better TRAILs for cancer treatment D de Miguel, J Lemke, A Anel, H Walczak, L Martinez-Lostao Cell Death & Differentiation 23 (5), 733-747, 2016 | 358 | 2016 |
| Differential secretion of Fas ligand-or APO2 ligand/TNF-related apoptosis-inducing ligand-carrying microvesicles during activation-induced death of human T cells I Monleón, MJ Martinez-Lorenzo, L Monteagudo, P Lasierra, M Taules, ... The Journal of Immunology 167 (12), 6736-6744, 2001 | 336 | 2001 |
| Involvement of APO2 ligand/TRAIL in activation‐induced death of Jurkat and human peripheral blood T cells MJ Martínez‐Lorenzo, MA Alava, S Gamen, KJ Kim, A Chuntharapai, ... European journal of immunology 28 (9), 2714-2725, 1998 | 273 | 1998 |
| T cell receptor‐induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A A Anel, M Buferne, C Boyer, AM Schmitt‐Verhulst, P Golstein European journal of immunology 24 (10), 2469-2476, 1994 | 261 | 1994 |
| A distinct pathway of cell-mediated apoptosis initiated by granulysin AA Kaspar, S Okada, J Kumar, FR Poulain, KA Drouvalakis, A Kelekar, ... The Journal of Immunology 167 (1), 350-356, 2001 | 214 | 2001 |
| Apoptotic pathways are selectively activated by granzyme A and/or granzyme B in CTL-mediated target cell lysis J Pardo, A Bosque, R Brehm, R Wallich, J Naval, A Müllbacher, A Anel, ... The Journal of cell biology 167 (3), 457-468, 2004 | 205 | 2004 |
| Granulysin-induced apoptosis. I. Involvement of at least two distinct pathways S Gamen, DA Hanson, A Kaspar, J Naval, AM Krensky, A Anel The Journal of Immunology 161 (4), 1758-1764, 1998 | 188 | 1998 |
| Immunogenic cell death and immunotherapy of multiple myeloma A Serrano-del Valle, A Anel, J Naval, I Marzo Frontiers in Cell and Developmental Biology 7, 50, 2019 | 186 | 2019 |
| Doxorubicin treatment activates a Z-VAD-sensitive caspase, which causes ΔΨm loss, caspase-9 activity, and apoptosis in Jurkat cells S Gamen, A Anel, P Pérez-Galán, P Lasierra, D Johnson, A Piñeiro, ... Experimental cell research 258 (1), 223-235, 2000 | 174 | 2000 |
| PKCη is required for β1γ2/β3γ2-and PKD-mediated transport to the cell surface and the organization of the Golgi apparatus AMD Añel, V Malhotra The Journal of cell biology 169 (1), 83-91, 2005 | 168 | 2005 |
| Granzymes are essential for natural killer cell‐mediated and perf‐facilitated tumor control J Pardo, S Balkow, A Anel, MM Simon European journal of immunology 32 (10), 2881-2886, 2002 | 159 | 2002 |
| Doxorubicin-induced apoptosis in human T-cell leukemia is mediated by caspase-3 activation in a Fas-independent way S Gamen, A Anel, P Lasierra, MA Alava, MJ Martinez-Lorenzo, A Piñeiro, ... FEBS letters 417 (3), 360-364, 1997 | 152 | 1997 |
| A role of the mitochondrial apoptosis-inducing factor in granulysin-induced apoptosis J Pardo, P Pérez-Galán, S Gamen, I Marzo, I Monleón, AA Kaspar, ... The journal of immunology 167 (3), 1222-1229, 2001 | 148 | 2001 |
| The biology of cytotoxic cell granule exocytosis pathway: granzymes have evolved to induce cell death and inflammation J Pardo, JI Aguilo, A Anel, P Martin, L Joeckel, C Borner, R Wallich, ... Microbes and infection 11 (4), 452-459, 2009 | 147 | 2009 |
| A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome M Del-Rey, J Ruiz-Contreras, A Bosque, S Calleja, J Gomez-Rial, ... Blood 108 (4), 1306-1312, 2006 | 146 | 2006 |
| Role of exosomes in the regulation of T-cell mediated immune responses and in autoimmune disease A Anel, A Gallego-Lleyda, D de Miguel, J Naval, L Martínez-Lostao Cells 8 (2), 154, 2019 | 139 | 2019 |
